If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.00
Bid: 15.50
Ask: 16.50
Change: 0.00 (0.00%)
Spread: 1.00 (6.452%)
Open: 15.75
High: 16.00
Low: 15.75
Prev. Close: 16.00
IHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of range extension of neonatal ventilators

23 Mar 2023 07:00

RNS Number : 9290T
Inspiration Healthcare Group PLC
23 March 2023
 

 23 March 2023

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Launch of range extension of specialist neonatal ventilators

Broadens the Company's reach into non-invasive ventilation

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, announces the launch of an extension to its range of neonatal ventilators. These are new variants of the SLE6000, Inspiration Healthcare's leading ventilator, that facilitates precise, controlled ventilation for critically ill infants. The products have been launched in the UK, where they will be sold directly and to selected international distributors. The roll out internationally will continue throughout the year.

 

The three new variants have been specifically designed to meet the specialist healthcare needs of some of the most vulnerable patients across critical care and high dependency care and all offer non-invasive respiratory support, which represents a new area of the market for the Company.

 

· The SLE6000H includes powerful high frequency oscillation, which actively controls pressure, volume and frequency to help protect the small and fragile lungs of critically ill patients;

· The SLE6000C includes full specification invasive and non-invasive modes, which can be easily adapted depenedent on the needs of the baby;

· The SLE6000N provides a suite of non-invasive, multi-mode respiratory support for less sick babies and those transitioning from respiratory support, enabling more important skin to skin contact between parents and baby.

 

Each variant also includes the option for Oxygenie®, the Company's automated oxygen control algorithm which is a key element in maintaining appropriate oxygen levels for neonates, helping to improve outcomes.

 

Neil Campbell, CEO of Inspiration Healthcare Group plc commented: "We're delighted to extend our range of ventilators with this launch, which is further demonstration of our continued commitment to pioneering innovative technologies to improve neonatal healthcare and help save the lives of premature babies around the world. We are excited about the potential of these products around the world."

 

For further information:

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Tel: +44 (0)330 175 0000

 

 

Cenkos Securities plc (Nominated Adviser & Broker)

Tel: +44 (0)207 397 8900

Stephen Keys, Katy Birkin, Dan Hodkinson

Walbrook PR Ltd (Media and Investor Relations)

Tel: +44 (0)20 7933 8780

Anna Dunphy/Stephanie Cuthbert

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in neonatal intensive care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.

 

The Company has key own brand products that can be used within the first days of life to help premature and sick babies; helping resuscitation and stabilisation in the first moments of life through to preventing brain damage and both invasive and non-invasive respiratory support in terms of capital equipment and disposable medical devices. Additionally, the Company has its own range of products for maintaining normothermia pre, during and post-surgery.

 

Since September 2019, the Company has acquired Vio Holdings a designer, manufacturer and supplier of single use respiratory products and sterile medical consumables and S.L.E., a leading designer, manufacturer and global provider of neonatal ventilation products. The Group generates approximately 58% of its revenues from export markets and more than half of its revenues come from its own-branded products.

 

With product availability actively promoted to over 80 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

 

In the UK and Ireland, the Group has direct sales teams selling Group Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

 

The Group operates from various sites in the UK for R&D, Marketing and operations with manufacturing based in Croydon (south London) and Hailsham (East Sussex). The Group's Head Office is located in Crawley, a short distance from London's Gatwick Airport.

 

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAZZGZFLZNGFZM
Date   Source Headline
7th Jul 20209:04 amRNSDirector/PDMR Dealings
7th Jul 20209:00 amRNSCompletion of Fundraising and Acquisition
7th Jul 20207:00 amRNSBoard Changes
6th Jul 20201:08 pmRNSResults of General Meeting & Open Offer
26th Jun 202012:10 pmRNSResult of AGM
26th Jun 20207:00 amRNSAppointment of CFO
26th Jun 20207:00 amRNSAGM Statement
22nd Jun 20209:40 amRNSTR1 Notification
19th Jun 20208:17 amRNSAcquisition, Placing, Open Offer and Notice of GM
18th Jun 20208:01 amRNSPDMR Dealing
16th Jun 20207:00 amRNSIssue of shares & total voting rights
15th Jun 20207:00 amRNSUpdate on Ventilator Delivery
11th Jun 20207:00 amRNSProject Wave awarded Innovation Support Grant
1st Jun 20207:00 amRNSNotice of AGM
6th May 20207:00 amRNSTrading Update
1st May 20207:00 amRNSNHS Orders Update
24th Apr 20207:00 amRNSDistribution agreement for AIHL test
24th Apr 20207:00 amRNSDistribution agreement for AIHL test
21st Apr 202011:00 amRNSReplacement - Final Results
21st Apr 20207:00 amRNSFinal Results
15th Apr 20202:01 pmRNSPrice Monitoring Extension
8th Apr 20207:36 amRNSPatents granted for FirstBreath™ breathing system
30th Mar 20204:29 pmRNSGrant of Options
25th Mar 20207:00 amRNSPatent granted for Project Wave
24th Mar 202011:08 amRNSTR1 Notification
20th Mar 20207:00 amRNSFurther Significant NHS Orders received
16th Mar 20207:00 amRNS£1.25 million NHS Order
26th Feb 20207:00 amRNSDirectorate Change
21st Feb 202012:59 pmRNSTR1 Notification
21st Feb 202010:05 amRNSTR1 Notification
20th Feb 20207:00 amRNSTrading Update
27th Jan 20207:00 amRNSGrowth & Innovation Forum 2020 and Arab Health
21st Jan 20207:00 amRNSEC certificates extended to May 2024
20th Jan 20207:00 amRNSSri Lankan Ministry of Health Order
9th Jan 202012:55 pmRNSTR1 Notification
7th Jan 20201:01 pmRNSTR1 Notification
31st Dec 20197:00 amRNSNPXe Files Chapter 11 to implement Asset Sale
30th Oct 20197:00 amRNSCosyTherm2 Launch and Investor Conference
2nd Oct 20197:00 amRNSInterim Results
26th Sep 201910:35 amRNSHolding(s) in Company
26th Sep 201910:32 amRNSHolding(s) in Company
25th Sep 20193:27 pmRNSHolding(s) in Company
24th Sep 20191:33 pmRNSHolding(s) in Company
24th Sep 201910:20 amRNSHolding(s) in Company
24th Sep 201910:17 amRNSHolding(s) in Company
24th Sep 201910:14 amRNSHolding(s) in Company
24th Sep 201910:11 amRNSHolding(s) in Company
24th Sep 201910:09 amRNSDirector/PDMR Shareholding
23rd Sep 20193:42 pmRNSResult of General Meeting
12th Sep 20197:00 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.